Bioneex
PrivateLast Round
Seed
Feb 15, 2024
Total Funding Raised
$500,000
Company Overview
Bioneex is a healthcare services company that operates an AI-powered platform connecting drug development companies with biopharma partners and venture capital investors for licensing, partnerships, and investments.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Marketplace Commission, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioneex Comparables
Compare Bioneex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clarivate Plc | 69% | |
| Norstella | 64% | |
| Techspert | 60% | |
Bioneex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 15, 2024 | ||||
| VC Round | Feb 15, 2024 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Monthly visitors increased 50% MoM.
- Nov 7, 2025
Monthly visitors increased 52% MoM, reaching 1.2K.
Bioneex Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bioneex's valuation, stock price, and market status.